[1]顾雨婷,梁程程,沈 聪,等.知柏地黄丸治疗卵巢储备功能低下不孕疗效研究[J].陕西中医,2022,(10):1376-1379.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.012]
　GU Yuting,LIANG Chengcheng,SHEN Cong,et al.Study on the effect and mechanism of Zhibai Dihuang pill on infertility with low ovarian reserve function[J].,2022,(10):1376-1379.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.012]
点击复制

知柏地黄丸治疗卵巢储备功能低下不孕疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年10期
页码:
1376-1379
栏目:
临床研究
出版日期:
2022-10-05

文章信息/Info

Title:
Study on the effect and mechanism of Zhibai Dihuang pill on infertility with low ovarian reserve function
作者:
顾雨婷; 梁程程; 沈 聪; 高晓晴
(上海中医药大学附属曙光医院妇科,上海 201203)
Author(s):
GU Yuting; LIANG Chengcheng; SHEN Cong; GAO Xiaoqing
(Department of Gynecology,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China)
关键词:
卵巢储备功能低下;  不孕症;  知柏地黄丸;  中医证候评分;  卵巢形态;  性激素
Keywords:
Low ovarian reserve function;  Infertility;  Zhibai Dihuang pill;  TCM symptom score;  Ovarian morphology;  Sex hormone
分类号:
R 271.14
DOI:
DOI:10.3969/j.issn.1000-7369.2022.10.012
文献标志码:
A
摘要:
目的:观察知柏地黄丸治疗卵巢储备功能低下不孕患者疗效及作用机制。方法:将90例卵巢储备功能低下的受试对象用随机数字表法平均分为对照组和观察组,每组45例。对照组予常规治疗,观察组在对照组基础上加用知柏地黄丸,比较两组患者治疗前后中医证候评分、临床疗效、卵巢形态、抗缪勒管激素(AMH)、性激素水平[促卵泡生成素(FSH)、促黄体生成素(LH)、雌二醇(E2)]、辅助T细胞1(Th1)、辅助T细胞2(Th2)细胞水平。结果:治疗后,两组患者中医证候评分结果均下降,观察组的中医证候评分低于对照组,差异有统计学意义(P<0.05)。治疗后,观察组临床总有效率(91.11%)高于对照组(71.11%),且差异有统计学意义(P<0.05)。治疗后,两组患者基础窦卵泡数、卵泡数增多,平均卵巢体积增大,子宫内膜厚度、卵巢动脉血舒张期及收缩期最高血流速度均增加,观察组各指标总体改善程度优于对照组,且差异有统计学意义(均P<0.05)。治疗后,两组患者的AMH、E2升高,FSH、LH降低(均P<0.05); 与对照组比较,观察组的AMH、E2水平较高,FSH、LH水平较低(均P<0.05)。治疗后,Th1较前下降,Th2较前升高,差异有统计学意义(均P<0.05); 与对照组比较,观察组Th1下降,Th2上升(均P<0.05)。与对照组比较,观察组妊娠率、月经恢复率均较高,流产率较低(均P<0.05)。结论:知柏地黄丸治疗卵巢储备功能低下不孕患者疗效较好,可改善AMH及性激素水平,其作用机制可能与调节Th1/Th2平衡有关。
Abstract:
Objective:To observe the efficacy and mechanism of Zhibai Dihuang pill in the treatment of infertile patients with low ovarian reserve.Methods:Ninety subjects with low ovarian reserve were equally divided into control group and observation group by random number table method,45 cases in each group.The control group was given routine treatment,and the observation group was given Zhibai Dihuang pill on the basis of the control group.The TCM symptom scores,clinical efficacy,ovarian morphology,anti-Mullerian hormone(AMH),and sex hormone levels [follicle-stimulating hormones(FSH),luteinizing hormone(LH),estradiol(E2)] were compared between the two groups before and after treatment,T helper 1(Th1),T helper 2(Th2)cell levels.Results:After treatment,the scores of TCM syndromes of the two groups of subjects decreased,and the TCM syndrome scores of the observation group were lower than those in the control group(P<0.05).After treatment,the total clinical effective rate(91.11%)of the subjects in the observation group was higher than that in the control group(71.11%)(P<0.05).After treatment,the basal number of antral follicles and follicles in the two groups increased,the average ovarian volume increased,the endometrial thickness,and the maximum blood flow velocity of ovarian artery blood in diastole and systole all increased.The overall improvement of the observation group was better than that in the control group(all P<0.05).After treatment,the levels of AMH and E2 in the two groups were increased,and the levels of FSH and LH were decreased(all P<0.05).Compared with the control group,the levels of AMH and E2 in the observation group were higher,and the levels of FSH and LH were lower(all P<0.05).After treatment,Th1 decreased and Th2 increased,and the difference was statistically significant(all P<0.05); compared with the control group,Th1 decreased and Th2 increased in the observation group(all P<0.05).Compared with the control group,the pregnancy rate and menstrual recovery rate of the observation group were higher,and the miscarriage rate was lower(all P<0.05).Conclusion:Zhibai Dihuang pill has good curative effect in the treatment of infertility patients with low ovarian reserve,and can improve the levels of AMH and sex hormones.Its mechanism of action may be related to the regulation of Th1/Th2 balance.

参考文献/References:

[1] 陈燕霞.补肾促卵方调控PI3K和Nrf2信号通路保护卵巢储备功能低下的机制研究[D].北京:中国中医科学院,2020.
[2] 杨 洋.卵巢储备功能低下中医证候与性激素的相关性研究[D].北京:北京中医药大学,2017.
[3] 于传鑫.实用妇科内分泌学[M].上海:复旦大学出版社,2004:15-18.
[4] 张明英,吴红英,严沁萌.自拟温肾活血方对卵巢储备功能低下患者中医症候评分、卵巢功能及血流动力学的影响[J].四川中医,2021,39(8):143-145.
[5] 国家药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:112-115.
[6] 王佳媛.脱氢表雄酮对卵巢储备功能低下患者性激素及妊娠率的影响[J].当代医学,2021,27(2):68-70.
[7] 滑 玮,刘朵朵,陈 琳,等.脱氢表雄酮(DHEA)治疗对卵巢低储备患者体外受精-胚胎移植周期的影响[J].陕西医学杂志,2017,46(8):1008-1011.
[8] 王春利,徐 洁.改良自然周期方案对卵巢储备功能低下患者临床疗效[J].中国计划生育学杂志,2020,28(11):1864-1867.
[9] 李 晶,高福贤,赵媛媛,等.腹腔镜输卵管吻合术对输卵管阻塞患者卵巢储备功能与免疫炎症反应的影响[J].陕西医学杂志,2019,48(2):220-222,236.
[10] 宋李丽.补肾活血方对卵巢储备功能低下患者中医症候积分及卵巢功能的影响[J].河南医学研究,2020,29(12):2240-2241.
[11] 纪 珮,陈小平.复方左归胶囊治疗卵巢储备功能低下不孕症疗效研究[J].陕西中医,2019,40(3):338-340.
[12] 张 妍.补肾活血方调节氧化应激改善肾虚血瘀患者卵巢储备功能低下的临床研究[D].南京:南京中医药大学,2020.
[13] 贾维宁,陈体辉,罗玉辉,等.知柏地黄丸对卵巢储备功能低下性激素水平及妊娠结局的影响[J].世界中医药,2020,15(7):1038-1041,1046.
[14] 王云欢,包晓霞,王必勤,等.卵巢储备功能下降的中医临床研究进展[J].现代中西医结合杂志,2019,28(5):563-566.
[15] 罗智华,姚吉龙.复发性流产患者主动免疫治疗前后种植窗外周血及子宫内膜淋巴细胞亚群变化[J].东南大学学报:医学版,2018,37(1):91-96.
[16] 于丹军,樊 静.妇科肿瘤患者外周血中调节性T细胞和血清中TGF-β、IL-10的变化及相关性研究[J].河北医科大学学报,2016,37(11):1307-1311,1316.
[17] 袁 芳.Th1/Th2和Th17/Treg平衡失调与宫颈癌发生发展关系及术后CD4+淋巴细胞亚群的改变[D].济南:山东大学,2014.
[18] 高 虹.育龄期SLE患者卵巢储备功能与淋巴细胞亚群变化的相关性初探[D].西安:第四军医大学,2017.
[19] 冯晓玲,贾紫千,李 娜,等.电针联合育阴丸对肝肾阴虚型卵巢储备功能下降患者性激素及Th2型细胞因子的影响[J].中国针灸,2020,40(9):959-963.
[20] 尹雅倩.针刺对卵巢储备功能减退模型大鼠HPO轴及FSH-cAMP信号通路的影响[D].北京:中国中医科学院,2020.

相似文献/References:

[1]纪 珮,陈小平,谢 波.复方左归胶囊治疗卵巢储备功能低下不孕症疗效研究*[J].陕西中医,2019,(3):338.
[2]严 莉,李 晶,黎玉宣,等.腹针联合脐疗对黄体功能低下型不孕症患者子宫内膜容受性的影响*[J].陕西中医,2020,(5):673.[doi:DOI:10.3969/j.issn.10007369.2020.05.034]
　YAN Li,LI Jing,LI Yuxuan,et al.The influence of abdominal acupuncture combined with umbilical therapy on endometrial receptivity in infertility patients caused by luteal phase deficiency[J].,2020,(10):673.[doi:DOI:10.3969/j.issn.10007369.2020.05.034]
[3]樊健敏,田 颖,白永利△,等.补肾活血汤对小卵泡排卵不孕症患者卵泡发育、卵巢动脉血流的影响*[J].陕西中医,2020,(10):1367.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.006]
　FAN Jianmin,TIAN Ying,BAI Yongli,et al.Effect of Bushen Huoxue decoction on follicular development and ovarian artery blood flow in infertile patients with small follicle ovulation[J].,2020,(10):1367.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.006]
[4]陈亚杰,闻 姬.子宫内膜异位症中西医认识及治疗研究进展[J].陕西中医,2021,(10):1486.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.043]
[5]凌丹凤,马丽然.补肾活血除湿法治疗早发性卵巢功能不全不孕症临床研究[J].陕西中医,2021,(12):1717.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.016]
　LING Danfeng,MA Liran.Clinical observation on the treatment of early-onset ovarian insufficiency infertility with Bushen Huoxue Chushi method[J].,2021,(10):1717.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.016]
[6]张 岩.国医大师夏桂成教授治疗多囊卵巢综合征致不孕数据挖掘研究[J].陕西中医,2022,(4):502.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.023]
　ZHANG Yan.A data mining research on infertility caused by polycystic ovary syndrome treated by Chinese medicine master professor XIA Guicheng[J].,2022,(10):502.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.023]
[7]罗 玲,李伟莉.李伟莉教授辨治未破裂卵泡黄素化综合征经验[J].陕西中医,2023,(6):777.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.022]

备注/Memo

备注/Memo:
基金项目:国家重点研发计划中医药现代化研究重点专项项目(2018YFC1704300)
更新日期/Last Update: 2022-10-09